Get started
Author

Zuzanna Maniecka

Observed name: Maniecka, Zuzanna
OpenAlex ID: A5038660912
Functional and dynamic polymerization of the ALS-linked protein TDP-43 antagonizes its pathologic aggregation
2017 · Tariq Afroz, Eva-Maria Hock, et al. · Nature Communications · 350
PDF
TDP-43 extracted from frontotemporal lobar degeneration subject brains displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression rates
2018 · Florent Laferrière, Zuzanna Maniecka, et al. · Nature Neuroscience · 186
From nucleation to widespread propagation: A prion-like concept for ALS
2015 · Zuzanna Maniecka, Magdalini Polymenidou · Virus Research · 61
PDF
Hypertonic Stress Causes Cytoplasmic Translocation of Neuronal, but Not Astrocytic, FUS due to Impaired Transportin Function
2018 · Eva-Maria Hock, Zuzanna Maniecka, et al. · Cell Reports · 59
PDF
A model of human neural networks reveals NPTX2 pathology in ALS and FTLD
2024 · Marian Hruska-Plochan, Vera I. Wiersma, et al. · Nature · 56
PDF
Identification of Amino Acid Residues of ERH Required for Its Recruitment to Nuclear Speckles and Replication Foci in HeLa Cells
2013 · Monika I. Banko, Marek K. Krzyzanowski, et al. · PLoS ONE · 14
PDF
Comprehensive evaluation of human-derived anti-poly-GA antibodies in cellular and animal models of C9orf72 disease
2022 · Melanie Jambeau, Kevin D. Meyer, et al. · Proceedings of the National Academy of Sciences · 12
Safety and efficacy of perioperative cisplatin/gemcitabine (cis/gem) and durvalumab (durva) for operable muscle-invasive urothelial carcinoma (MIUC): SAKK 06/17.
2021 · Richard Cathomas, Sacha Rothschild, et al. · Journal of Clinical Oncology · 12
TDP-43 extracted from frontotemporal lobar degeneration subject brains displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression rates
2019 · Laferrière, Florent; https://orcid.org/0000-0002-0753-5505, Maniecka, Zuzanna, et al. · Zurich Open Repository and Archive (University of Zurich) · 11
Human neural networks with sparse TDP-43 pathology reveal NPTX2 misregulation in ALS/FTLD
2021 · Marian Hruska-Plochan, Katharina M. Betz, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 10
PDF
A model of human neural networks reveals NPTX2 pathology in ALS and FTLD
2024 · Hruska-Plochan, Marian; https://orcid.org/0000-0002-9253-4362, Wiersma, Vera I; https://orcid.org/0000-0001-8223-4588, et al. · Zurich Open Repository and Archive (University of Zurich) · 4
Alternate-day dosing of pomalidomide in relapsed/ refractory multiple myeloma: a multicenter, single-arm phase 2 trial
2023 · Thilo Zander, Thomas Pabst, et al. · Leukemia · 4
PDF
P-227: Alternate day dosing of pomalidomide in patients with refractory/relapsed multiple myeloma (RRMM): Results of a multicenter, single arm phase 2 trial (SAKK 39/16 OptiPOM Study)
2021 · Thilo Zander, Thomas Pabst, et al. · Clinical Lymphoma Myeloma & Leukemia
Physiological and pathological TDP-43 assemblies and new ALS/FTD neuronal models
2018 · Zuzanna Maniecka · Zurich Open Repository and Archive (University of Zurich)
Works count: 19
Citation count: 779
H-index: 10
I10-index: 10
Year
Topic
Type